Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis

Multiple sclerosis (MS) is an increasingly prevalent progressive autoimmune and debilitating chronic disease that involves the detrimental recognition of central nervous system (CNS) antigens by the immune system. Although significant progress has been made in the last decades on the biology of MS a...

Full description

Bibliographic Details
Main Authors: Luisa F. Duarte, María J. Altamirano-Lagos, Jorge H. Tabares-Guevara, Ma. Cecilia Opazo, Máximo Díaz, Romina Navarrete, Catalina Muza, Omar P. Vallejos, Claudia A. Riedel, Susan M. Bueno, Alexis M. Kalergis, Pablo A. González
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.635257/full
id doaj-89f198f720cb45c3934a7836314531e9
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Luisa F. Duarte
Luisa F. Duarte
María J. Altamirano-Lagos
María J. Altamirano-Lagos
Jorge H. Tabares-Guevara
Jorge H. Tabares-Guevara
Ma. Cecilia Opazo
Ma. Cecilia Opazo
Máximo Díaz
Máximo Díaz
Romina Navarrete
Romina Navarrete
Catalina Muza
Catalina Muza
Omar P. Vallejos
Omar P. Vallejos
Claudia A. Riedel
Claudia A. Riedel
Susan M. Bueno
Susan M. Bueno
Alexis M. Kalergis
Alexis M. Kalergis
Alexis M. Kalergis
Pablo A. González
Pablo A. González
spellingShingle Luisa F. Duarte
Luisa F. Duarte
María J. Altamirano-Lagos
María J. Altamirano-Lagos
Jorge H. Tabares-Guevara
Jorge H. Tabares-Guevara
Ma. Cecilia Opazo
Ma. Cecilia Opazo
Máximo Díaz
Máximo Díaz
Romina Navarrete
Romina Navarrete
Catalina Muza
Catalina Muza
Omar P. Vallejos
Omar P. Vallejos
Claudia A. Riedel
Claudia A. Riedel
Susan M. Bueno
Susan M. Bueno
Alexis M. Kalergis
Alexis M. Kalergis
Alexis M. Kalergis
Pablo A. González
Pablo A. González
Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
Frontiers in Immunology
HSV-1
viral infection
multiple sclerosis
experimental autoimmune encephalomyelitis
neuroinflammation
author_facet Luisa F. Duarte
Luisa F. Duarte
María J. Altamirano-Lagos
María J. Altamirano-Lagos
Jorge H. Tabares-Guevara
Jorge H. Tabares-Guevara
Ma. Cecilia Opazo
Ma. Cecilia Opazo
Máximo Díaz
Máximo Díaz
Romina Navarrete
Romina Navarrete
Catalina Muza
Catalina Muza
Omar P. Vallejos
Omar P. Vallejos
Claudia A. Riedel
Claudia A. Riedel
Susan M. Bueno
Susan M. Bueno
Alexis M. Kalergis
Alexis M. Kalergis
Alexis M. Kalergis
Pablo A. González
Pablo A. González
author_sort Luisa F. Duarte
title Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
title_short Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
title_full Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
title_fullStr Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
title_full_unstemmed Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
title_sort asymptomatic herpes simplex virus type 1 infection causes an earlier onset and more severe experimental autoimmune encephalomyelitis
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-02-01
description Multiple sclerosis (MS) is an increasingly prevalent progressive autoimmune and debilitating chronic disease that involves the detrimental recognition of central nervous system (CNS) antigens by the immune system. Although significant progress has been made in the last decades on the biology of MS and the identification of novel therapies to treat its symptoms, the etiology of this disease remains unknown. However, recent studies have suggested that viral infections may contribute to disease onset. Interestingly, a potential association between herpes simplex virus type 1 (HSV-1) infection and MS has been reported, yet a direct relationship among both has not been conclusively demonstrated. Experimental autoimmune encephalomyelitis (EAE) recapitulates several aspects of MS in humans and is widely used to study this disease. Here, we evaluated the effect of asymptomatic brain infection by HSV-1 on the onset and severity of EAE in C57BL/6 mice. We also evaluated the effect of infection with an HSV-1-mutant that is attenuated in neurovirulence and does not cause encephalitis. Importantly, we observed more severe EAE in mice previously infected either, with the wild-type (WT) or the mutant HSV-1, as compared to uninfected control mice. Also, earlier EAE onset was seen after WT virus inoculation. These findings support the notion that a previous exposure to HSV-1 can accelerate and enhance EAE, which suggests a potential contribution of asymptomatic HSV-1 to the onset and severity of MS.
topic HSV-1
viral infection
multiple sclerosis
experimental autoimmune encephalomyelitis
neuroinflammation
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.635257/full
work_keys_str_mv AT luisafduarte asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT luisafduarte asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT mariajaltamiranolagos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT mariajaltamiranolagos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT jorgehtabaresguevara asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT jorgehtabaresguevara asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT maceciliaopazo asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT maceciliaopazo asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT maximodiaz asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT maximodiaz asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT rominanavarrete asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT rominanavarrete asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT catalinamuza asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT catalinamuza asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT omarpvallejos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT omarpvallejos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT claudiaariedel asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT claudiaariedel asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT susanmbueno asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT susanmbueno asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT alexismkalergis asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT alexismkalergis asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT alexismkalergis asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT pabloagonzalez asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
AT pabloagonzalez asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis
_version_ 1724269202041208832
spelling doaj-89f198f720cb45c3934a7836314531e92021-02-15T04:50:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-02-011210.3389/fimmu.2021.635257635257Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune EncephalomyelitisLuisa F. Duarte0Luisa F. Duarte1María J. Altamirano-Lagos2María J. Altamirano-Lagos3Jorge H. Tabares-Guevara4Jorge H. Tabares-Guevara5Ma. Cecilia Opazo6Ma. Cecilia Opazo7Máximo Díaz8Máximo Díaz9Romina Navarrete10Romina Navarrete11Catalina Muza12Catalina Muza13Omar P. Vallejos14Omar P. Vallejos15Claudia A. Riedel16Claudia A. Riedel17Susan M. Bueno18Susan M. Bueno19Alexis M. Kalergis20Alexis M. Kalergis21Alexis M. Kalergis22Pablo A. González23Pablo A. González24Millennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileDepartamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMultiple sclerosis (MS) is an increasingly prevalent progressive autoimmune and debilitating chronic disease that involves the detrimental recognition of central nervous system (CNS) antigens by the immune system. Although significant progress has been made in the last decades on the biology of MS and the identification of novel therapies to treat its symptoms, the etiology of this disease remains unknown. However, recent studies have suggested that viral infections may contribute to disease onset. Interestingly, a potential association between herpes simplex virus type 1 (HSV-1) infection and MS has been reported, yet a direct relationship among both has not been conclusively demonstrated. Experimental autoimmune encephalomyelitis (EAE) recapitulates several aspects of MS in humans and is widely used to study this disease. Here, we evaluated the effect of asymptomatic brain infection by HSV-1 on the onset and severity of EAE in C57BL/6 mice. We also evaluated the effect of infection with an HSV-1-mutant that is attenuated in neurovirulence and does not cause encephalitis. Importantly, we observed more severe EAE in mice previously infected either, with the wild-type (WT) or the mutant HSV-1, as compared to uninfected control mice. Also, earlier EAE onset was seen after WT virus inoculation. These findings support the notion that a previous exposure to HSV-1 can accelerate and enhance EAE, which suggests a potential contribution of asymptomatic HSV-1 to the onset and severity of MS.https://www.frontiersin.org/articles/10.3389/fimmu.2021.635257/fullHSV-1viral infectionmultiple sclerosisexperimental autoimmune encephalomyelitisneuroinflammation